Sandbox:Sahar: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 115: Line 115:
! style="padding: 5px 5px; background: #F5F5F5; " |In case of low clinical
! style="padding: 5px 5px; background: #F5F5F5; " |In case of low clinical


probability of AAS, negative Ddimer
probability of AAS, negative D-dimer


levels should be
levels should be
Line 130: Line 130:
probability of AAS with a
probability of AAS with a


positive (point-of-care) Ddimer
positive (point-of-care) D-dimer


test, further imaging
test, further imaging

Revision as of 17:44, 24 December 2019

Recomendacations Class Level References
History and clinical assessment
In all patients with suspected

AAS, pre-test probability

assessment is recommended,

according to the patient’s

condition, symptoms, and

clinical features.

Laboratory testing
In case of suspicion of AAS,

the interpretation of

biomarkers should always be

considered along with the pretest

clinical probability.

In case of low clinical

probability of AAS, negative D-dimer

levels should be

considered as ruling out the

diagnosis.

In case of intermediate clinical

probability of AAS with a

positive (point-of-care) D-dimer

test, further imaging

tests should be considered.

In patients with high probability

(risk score 2 or 3) of AD,

testing of D-dimers is not

recommended.

Imaging
TTE is recommended as an

initial imaging investigation.

In unstabled patients with a

suspicion of AAS, the following

imaging modalities are

recommended according to

local availability and expertise:

TOE
CT
In stable patients with a

suspicion of AAS, the

following imaging modalities

are recommended (or should

be considered) according to

local availability and expertise:

CT
MRI
TOE